Elizabeth F Sutton1, Sarah C Rogan, Samia Lopa, Danielle Sharbaugh, Matthew F Muldoon, Janet M Catov. 1. Magee-Womens Research Institute, the Department of Obstetrics, Gynecology and Reproductive Sciences and the UPMC Heart and Vascular Institute, University of Pittsburgh School of Medicine, and the Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania.
Abstract
OBJECTIVE: To investigate whether women with early pregnancy elevated blood pressure (BP) or stage 1 hypertension exhibit increased risk of preeclampsia and maternal or neonatal morbidity. METHODS: We conducted a clinical cohort study of 18,162 women who delivered a singleton neonate from 2015 to 2018 and attended at least two prenatal appointments before 20 weeks of gestation. Data were collected within the Magee Obstetric Maternal and Infant database, an aggregate of prenatal and delivery health records. Early pregnancy BP was defined as average BP before 20 weeks of gestation, and women were classified with normal, elevated BP, stage 1 or 2 hypertension according to current guidelines. The primary outcome was preeclampsia. Secondary outcomes were severe maternal morbidity, placental abruption, gestational diabetes, and composite neonatal morbidity. RESULTS: Overall, 75.2% of the women were categorized with normal BP, 13.9% with elevated BP, 5.4% with stage 1 hypertension, and 5.5% with stage 2 hypertension. Risk of preeclampsia increased in a stepwise fashion with increasing BP category, adjusted for covariates (normal BP, 4.7%, referent; elevated BP, 7.3%, adjusted odds ratio [aOR] 1.29, 95% CI 1.07-1.56; stage 1, 12.3%, aOR 2.35, 95% CI 1.86-2.96), and stage 2, 30.2%, aOR 6.49, 95% CI 5.34-7.89). Results were similar among black and white women. Gestational diabetes was more prevalent among women with stage 1 (11.4%; aOR 1.50, 95% CI 1.18-1.91] and stage 2 hypertension (14.2%; aOR 1.65, 95% CI 1.30-2.10). Severe maternal morbidity and neonatal morbidity were increased only among women with stage 2 hypertension (aOR 2.99, 95% CI 2.26-3.99, and aOR 2.67, 95% CI 2.28-3.12, respectively). CONCLUSION: Women with elevated BP, and stage 1 and 2 hypertension in early pregnancy are at increased risk for preeclampsia. These findings emphasize the importance of applying the 2017 BP guidelines to reproductive-aged women. Strategies to incorporate these guidelines into obstetric care may also be warranted.
OBJECTIVE: To investigate whether women with early pregnancy elevated blood pressure (BP) or stage 1 hypertension exhibit increased risk of preeclampsia and maternal or neonatal morbidity. METHODS: We conducted a clinical cohort study of 18,162 women who delivered a singleton neonate from 2015 to 2018 and attended at least two prenatal appointments before 20 weeks of gestation. Data were collected within the Magee Obstetric Maternal and Infant database, an aggregate of prenatal and delivery health records. Early pregnancy BP was defined as average BP before 20 weeks of gestation, and women were classified with normal, elevated BP, stage 1 or 2 hypertension according to current guidelines. The primary outcome was preeclampsia. Secondary outcomes were severe maternal morbidity, placental abruption, gestational diabetes, and composite neonatal morbidity. RESULTS: Overall, 75.2% of the women were categorized with normal BP, 13.9% with elevated BP, 5.4% with stage 1 hypertension, and 5.5% with stage 2 hypertension. Risk of preeclampsia increased in a stepwise fashion with increasing BP category, adjusted for covariates (normal BP, 4.7%, referent; elevated BP, 7.3%, adjusted odds ratio [aOR] 1.29, 95% CI 1.07-1.56; stage 1, 12.3%, aOR 2.35, 95% CI 1.86-2.96), and stage 2, 30.2%, aOR 6.49, 95% CI 5.34-7.89). Results were similar among black and white women. Gestational diabetes was more prevalent among women with stage 1 (11.4%; aOR 1.50, 95% CI 1.18-1.91] and stage 2 hypertension (14.2%; aOR 1.65, 95% CI 1.30-2.10). Severe maternal morbidity and neonatal morbidity were increased only among women with stage 2 hypertension (aOR 2.99, 95% CI 2.26-3.99, and aOR 2.67, 95% CI 2.28-3.12, respectively). CONCLUSION: Women with elevated BP, and stage 1 and 2 hypertension in early pregnancy are at increased risk for preeclampsia. These findings emphasize the importance of applying the 2017 BP guidelines to reproductive-aged women. Strategies to incorporate these guidelines into obstetric care may also be warranted.
Authors: Elliott K Main; Anisha Abreo; Jennifer McNulty; William Gilbert; Colleen McNally; Debra Poeltler; Katarina Lanner-Cusin; Douglas Fenton; Theresa Gipps; Kathryn Melsop; Naomi Greene; Jeffrey B Gould; Sarah Kilpatrick Journal: Am J Obstet Gynecol Date: 2015-11-12 Impact factor: 8.661
Authors: Jillian T Henderson; Evelyn P Whitlock; Elizabeth O'Connor; Caitlyn A Senger; Jamie H Thompson; Maya G Rowland Journal: Ann Intern Med Date: 2014-05-20 Impact factor: 25.391
Authors: Pensée Wu; Randula Haththotuwa; Chun Shing Kwok; Aswin Babu; Rafail A Kotronias; Claire Rushton; Azfar Zaman; Anthony A Fryer; Umesh Kadam; Carolyn A Chew-Graham; Mamas A Mamas Journal: Circ Cardiovasc Qual Outcomes Date: 2017-02-22
Authors: Jacob A Lykke; Jens Langhoff-Roos; Baha M Sibai; Edmund F Funai; Elizabeth W Triche; Michael J Paidas Journal: Hypertension Date: 2009-05-11 Impact factor: 10.190
Authors: Elizabeth F Sutton; Alisse Hauspurg; Steve N Caritis; Robert W Powers; Janet M Catov Journal: Obstet Gynecol Date: 2018-10 Impact factor: 7.661
Authors: Erica P Gunderson; Mara Greenberg; Mai N Nguyen-Huynh; Cassidy Tierney; James M Roberts; Alan S Go; Wei Tao; Stacey E Alexeeff Journal: Hypertension Date: 2021-12-29 Impact factor: 10.190
Authors: Jack Milln; Betty Nakabuye; Barnabas Natamba; Isaac Sekitoleko; Michael Mubiru; Arthur Namara; Samuel Tumwesigire; Tino Salome; Mandy Mirembe; Ayoub Kakanda; Brian Agaba; Faridah Nansubuga; Daniel Zaake; Ben Ayiko; Herbert Kalema; Sarah Nakubulwa; Musa Sekikubo; Annettee Nakimuli; Emily L Webb; Moffat J Nyirenda Journal: AJOG Glob Rep Date: 2021-05